Business Context and Reporting Period
This Form 8-K is filed by WiSA Technologies, Inc. (not Datavault AI Inc.) on December 20, 2024. The company is incorporated in Delaware and trades on The Nasdaq Capital Market under the symbol WISA. The filing reports the entry into material definitive agreements regarding the extension and modification of warrant inducement programs.
Key Financial Metrics and Agreements
- Potential Proceeds: If all Existing Warrants are exercised under the new December Inducement Agreements, the Company expects to receive aggregate gross proceeds of approximately $2.9 million.
- Exercise Price: The per-share exercise price for the Existing Warrants and the new Inducement Warrants is $1.70.
- Warrant Volume: The Existing Warrants are exercisable for up to 1,675,803 shares of Common Stock.
- Inducement Ratio: Holders exercising Existing Warrants by December 31, 2024, will receive new Inducement Warrants for shares equal to 150% of the shares issued upon exercise of the Existing Warrants.
- Debt and Liquidity: The filing text does not provide specific values for current debt levels, cash flow, or liquidity metrics.
Material Changes and Agreements
Amendment to September Inducement Agreements
The Company entered into a fourth amendment to its September Inducement Agreements, extending the "Inducement Period" for exercising Exchange Warrants from December 31, 2024, to January 31, 2025. Holders exercising during this period receive new warrants for 65% of the shares issued upon exercise.
December Inducement Agreements
New inducement agreements were executed with Existing Warrant Holders (from a March 2024 purchase agreement). Key terms include:
- Exercise Deadline: Holders must exercise Existing Warrants by December 31, 2024 to qualify for the 150% inducement.
- Stockholder Approval: The new Inducement Warrants cannot be exercised until stockholder approval is obtained. The Company must hold a meeting within 60 days of the agreement date (by February 18, 2025).
- Registration: The Company must file a resale registration statement by January 31, 2025.
- Participation Rights: Upon full exercise of Existing Warrants, the Original Participation Right terminates. Holders receive a new right to participate in up to 40% of future offerings (pro rata) until March 27, 2027.
Outlook, Risks, and Contingencies
- Uncertainty of Proceeds: There is no guarantee that all Existing Warrants will be exercised; the $2.9 million figure is contingent on full exercise.
- Regulatory Contingency: The issuance of Inducement Warrant Shares is contingent upon stockholder approval and the effectiveness of a resale registration statement.
- Expiration: The Inducement Warrants will expire on the fifth anniversary of the Stockholder Approval Date.
- Costs: The $2.9 million gross proceeds figure is before deducting financial advisory fees and other expenses payable by the Company.
Investor Verification Checklist
- Verify the actual number of Existing Warrants exercised by the December 31, 2024 deadline to determine actual capital raised.
- Confirm the date and outcome of the stockholder meeting required to approve the issuance of Inducement Warrant Shares.
- Monitor the filing and effectiveness status of the Resale Registration Statement due by January 31, 2025.
- Review the specific financial advisory fees and expenses that will reduce the gross proceeds.
- Check for any subsequent filings regarding the exercise of the September Inducement Agreements extended to January 31, 2025.